Skip to main content

Prototype Prescribing Outlier Dashboard for Sorrel Bank Medical Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Sorrel Bank Medical Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Low protein risotto 1 Foods for special diets 295 0.00 0.00 0.00 11.14
Hepatitis B 8 Vaccines and antisera 10 0.80 0.02 0.11 6.78
Low protein cereals 15 Foods for special diets 295 0.05 0.00 0.01 6.42
Low protein mixes 39 Foods for special diets 295 0.13 0.01 0.02 5.14
Acenocoumarol 36 Oral anticoagulants 2,496 0.01 0.00 0.00 4.69
Triptorelin 21 Prostate cancer and gonadorelin analogues 27 0.78 0.09 0.16 4.45
Miconazole nitrate 23 Vaginal and vulval infections 140 0.16 0.01 0.03 4.42
Low protein biscuits 21 Foods for special diets 295 0.07 0.00 0.02 4.34
Valaciclovir 37 Herpes simplex and varicella-zoster 122 0.30 0.04 0.06 4.27
Low protein grains/flours 6 Foods for special diets 295 0.02 0.00 0.00 4.14

Prescribing where Sorrel Bank Medical Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Aciclovir 85 Herpes simplex and varicella-zoster 122 0.70 0.95 0.07 -3.86
Influenza 0 Vaccines and antisera 10 0.00 0.88 0.28 -3.13
    Hydralazine hydrochloride 0 Vasodilator antihypertensive drugs 3 0.00 0.85 0.28 -3.04
      Glucose 4 Treatment of hypoglycaemia 18 0.22 0.75 0.20 -2.66
      Alfentanil hydrochloride 0 Opioid analgesics 15 0.00 0.82 0.38 -2.18
        Losartan potassium 396 Angiotensin-II receptor antagonists 3,043 0.13 0.50 0.19 -2.00
        Fusidic acid 38 Antibacterial preparations also used systemically 81 0.47 0.75 0.14 -1.97
        Clotrimazole 103 Vaginal and vulval infections 140 0.74 0.90 0.09 -1.95
        Quinine sulfate 234 Antimalarials 368 0.64 0.90 0.14 -1.92
        Dexamethasone 76 Otitis externa 131 0.58 0.78 0.12 -1.63